Evidence map›Paper›PMID 26131142›Full record

ArticleInternational journal of clinical and experimental medicine2015

Matrine regulates immune functions to inhibit the proliferation of leukemic cells.

Lei Zhang, Huizhang Zhang, Zhichao Zhu, Lijia Jiang, Xuzhang Lu, Min Zhou, Xiao Sun, Liuyang He, Yu Bai, Lingdi Ma

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Research Advances on Matrine.Frontiers in chemistry · 2022
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lei ZhangDepartment of Advanced Medical Service, Tongji Hospital, Tongji University Shanghai 200065, China.
Huizhang ZhangDepartment of Laboratory Medicine, Jinshan Hospital, Fudan University Shanghai 201508, China.
Zhichao ZhuLaboratary Center, Changzhou No. 2 People's Hospital, The Affiliated Hospital of Nanjing Medical University Changzhou 213000, China.
Lijia JiangLaboratary Center, Changzhou No. 2 People's Hospital, The Affiliated Hospital of Nanjing Medical University Changzhou 213000, China.
Xuzhang LuDepartment of Hematology, Changzhou No. 2 People's Hospital, The Affiliated Hospital of Nanjing Medical University Changzhou 213000, China.
Min ZhouDepartment of Hematology, Changzhou No. 2 People's Hospital, The Affiliated Hospital of Nanjing Medical University Changzhou 213000, China.
Xiao SunLaboratary Center, Changzhou No. 2 People's Hospital, The Affiliated Hospital of Nanjing Medical University Changzhou 213000, China.
Liuyang HeLaboratary Center, Changzhou No. 2 People's Hospital, The Affiliated Hospital of Nanjing Medical University Changzhou 213000, China.
Yu BaiLaboratary Center, Changzhou No. 2 People's Hospital, The Affiliated Hospital of Nanjing Medical University Changzhou 213000, China.
Lingdi MaLaboratary Center, Changzhou No. 2 People's Hospital, The Affiliated Hospital of Nanjing Medical University Changzhou 213000, China.
Changzhou No.2 People's Hospital · CNJinshan Hospital of Fudan University · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo investigate the roles of matrine in regulating immune functions and its effect on the proliferation of leukemic cells.

methodsHuman leukemia K562, OUN-1, HL-60, U937, K562/AO2 cell lines and primary leukemic cells were used to detect the NKG2D ligands (NKG2DL) expression such as MICA/B, ULBP-1, ULBP-2, ULBP-3, and NK cells receptor NKG2D, CD158a, CD158b were detected by flow cytometry. Cell cytotoxic activity of human NK cells and CIK cells against K562 leukemia cells was detected using CFSE/PI double staining. Pro-inflammatory cytokines and adhesion molecules in K562 or NK cells supernatant after matrine treatment were detected.

resultsMatrine could upregulate the expression of NKG2DL on leukemic cell lines, and primary leukemic cells and enhance the NK and CIK cytotoxicity targeted to K562 cells. After matrine treatment, pro-inflammatory cytokines and adhesion molecular such as IL-6, IL-1, IL-2, IL-4, IL-5, GRO and TNF-α in K562 cells supernatant were significantly decreased (P < 0.05). Flow cytometry analysis showed that the NKG2D expression was up-regulated significantly as well as the CD158a and CD158b expression decreased after treatment with different concentration of matrine in a dose-dependent manner in K562 cells. A significant decrease of supernatant concentrations of IL-1α, IL-5, IL-6, IL-10, IFN-γ, GRO and TNF-α in NK cells was also observed after exposure to the matrine.

conclusionMatrine regulates immune functions to inhibit the proliferation of leukemic cells.

Indexed as

immune functionsluekemia cellsMatrineNK cells

Identifiers

PMID26131142
PMCPMC4484016
OpenAlexW2249089699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.